Simulation modelling for the design and management of biopharmaceutical supply chains

Simulation modelling for the design and management of biopharmaceutical supply chains

BACKGROUND:

  • Biopharmaceutical products are normally used to treat serious diseases, therefore their availability – or lack thereof – is often a matter of life and death. In the biopharmaceutical sector, manufacturing processes and supply chain management are significantly more complex than those of the traditional pharmaceutical sector.
  • Weak manufacturing and supply chain processes can generate unacceptable long lead times and high levels of uncertainty in terms of output. Therefore, forecasting and planning are particularly crucial in this area.

APPROACH:

  • SKKIP proposes the use of simulation modelling techniques to create a model mimicking the system in a digital, risk-free environment.
  • The virtual digital replica of the real system – an extension of the Digital Twin concept – allows to identify the optimal operating conditions and explore various potential alternatives.

BENEFITS:

  • Reduction in costs and risks.
  • Greater overall understanding of supply chain management (SCM) processes and characteristics, thus allowing for a better allocation of resources and improvement in the overall quality of customers' healthcare.
  • Minimisation of the risk of changes in the planning of SCM processes.